Donor-derived 19-28z CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-derived 19-28z CAR T cells, covering 2025-05-13 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies [Phase 1]